Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Conba Pharmaceutical is a prominent Chinese pharmaceutical enterprise focused on the modernization of Traditional Chinese Medicine (TCM) alongside the production of chemical drugs. The company maintains a diverse portfolio with market-leading products in cardiovascular health, digestive systems, and urology, notably its Ginkgo biloba extract and Omeprazole formulations. Headquartered in Hangzhou, Conba operates extensive manufacturing facilities and R&D centers, positioning itself as a key player in China's healthcare sector. Since 2020, the company has been under the control of the Zhejiang Provincial International Trade Group, facilitating its integration into state-led healthcare initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Kang'enbei Traditional Chinese Medicine.